GSTO2 and COVID-19: Having in mind beneficial effects of vitamin C on COVID-19 patients [8], low DHAR activity in patients with both variant GSTO2 alleles may result in deficient vitamin C regeneration and accumulation of the oxidized form, dehydroascorbate, contributing to disruption of redox homeostasis.